Literature DB >> 19895339

Cardiovascular and cerebrovascular events in temporal relationship to intravenous glucocorticoid pulse therapy in patients with severe endocrine ophthalmopathy.

Maria E Lendorf, Ase Krogh Rasmussen, Hans C Fledelius, Ulla Feldt-Rasmussen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19895339     DOI： 10.1089/thy.2009.0069

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  7 in total

1.  Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy.

Authors:  M Riedl; E Kolbe; E Kampmann; I Krämer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-01-10       Impact factor: 4.256

2.  Safety of Intravenous Methylprednisolone in Refractory and Severe Pediatric Uveitis.

Authors:  Hashem H Ghoraba; Wataru Matsumiya; Hassan Khojasteh; Amir Akhavanrezayat; Irmak Karaca; Christopher Or; Negin Yavari; Sherin Lajevardi; Jaclyn Hwang; Cigdem Yasar; Diana Do; Quan Dong Nguyen
Journal:  Clin Ophthalmol       Date:  2022-05-31

3.  Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease.

Authors:  Kai-Ling Yong; Chiaw Ling Chng; Hla Myint Htoon; Lee Hooi Lim; Lay Leng Seah
Journal:  Int J Endocrinol       Date:  2015-11-22       Impact factor: 3.257

Review 4.  Glucocorticoids in Graves' orbitopathy: mechanisms of action and clinical application.

Authors:  Jan Längericht; Irene Krämer; George J Kahaly
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-14       Impact factor: 3.565

5.  Efficacy and safety of tripterygium glycosides for active moderate to severe Graves' ophthalmopathy: a randomised, observer-masked, single-centre trial.

Authors:  Xiaozhen Ye; Heng Zhao; Jun Liu; Bin Lu; Jiaqing Shao; Jian Wang
Journal:  Eur J Endocrinol       Date:  2021-02       Impact factor: 6.664

Review 6.  Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves' orbitopathy.

Authors:  Dorota Walasik-Szemplińska; Grzegorz Kamiński; Iwona Sudoł-Szopińska
Journal:  Thyroid Res       Date:  2019-12-23

7.  Acute bilateral cerebral infarction in the presence of neuromyelitis optica spectrum disorder: A case report.

Authors:  Zi-Yi Wang; Meng Wang; Jiao-Jiao Guo; Yan-Lu Gao; Xue-Fan Yu
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.